The Global End to End CDMO That’s Always Ahead of your Needs
We help our partners accelerate to market.
Our Mission
We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.
Our Vision
To be the most client-centric and reliable CDMO, accelerating therapies to market and enriching the lives of all stakeholders.
Our Offerings
Our deeply tenured teams are here to bring your ambitions to life. We provide scientific and operational excellence from process development through the cGMP clinical and commercial scale manufacturing of microbial, pDNA and mRNA-based vaccines, LNP and drug product.
Microbial
Bacterial protein expression platforms for all types of microbial products, including whole cell vaccines.
Plasmid DNA
Process development and bulk cGMP DNA adjuvants and plasmids, pDNA for vaccines, cell and gene therapies and templates for mRNA production.
mRNA
Messenger RNA for preclinical research, toxicology studies, clinical trials and commercial production for mRNA therapeutics and vaccines.
LNP
Lipid Nanoparticle (LNP) encapsulation services offering can support a wide range of applications.
Drug Product
Development, formulation, and analytical services for sterile liquids, clinical and commercial fill and finish manufacturing for small molecules and biologics.
Our Services
We deliver on-time and in-full for our clients every step of the way from idea to end product. We’re always inspection-ready and provide unmatched service with all the intangibles that make our client relationships stand the test of time.
Technology Transfer
Regardless of where your product is in its lifecycle, we’ll optimise your process and accelerate your path forward. Our dedicated project management and technical teams follow robust, standardised tech transfer procedures supported by comprehensive quality systems. We work collaboratively to optimise your process, minimise variability, and ensure successful scale-up for clinical or commercial production. At BioCina, every transfer is treated with care, precision, and urgency—because we know every batch matters.
Process Development
At BioCina, we believe the process is the product. Our expert teams partner with you early to design and optimise robust, scalable, and commercially viable processes across microbial biologics, plasmid DNA, mRNA, LNP and sterile injectables.
We help shorten timelines, minimise scale-up risks, reduce cost of goods, and ensure smooth tech transfer—setting your program up for success from day one.
Analytical Development
At BioCina, analytical excellence drives every step of your product journey. We offer seamless, end-to-end services—method transfer, development, qualification, and validation—ensuring consistency and compliance from pre-clinical to commercial.
Our expert team supports a wide range of modalities, including microbial biologics, plasmid DNA, mRNA, LNP, small molecules, and cytotoxics—delivering reliable data to power your success.
cGMP Manufacturing
Scale with confidence. BioCina delivers flexible, phase-appropriate GMP manufacturing—from pre-clinical to commercial—across microbial biologics, plasmid DNA (pDNA), mRNA, LNP and sterile injectables.
With state-of-the-art sites in Adelaide and Perth, and a proven track record of on-time, in-full delivery, we ensure global compliance and inspection readiness at every stage.
Quality and Regulatory
Quality and compliance are at the core of everything we do.
At BioCina, quality is embedded at every stage. We operate to the highest global standards—including TGA, FDA, EMA, and Health Canada—ensuring robust oversight through clinical trials, validation, and submissions. Our dedicated quality and regulatory teams support inspection readiness and guide you confidently through complex approval pathways.
Our Four Differentiators
Deeply Rooted
BioCina’s Roots Run Deep
Our highly experienced operational and technical teams bring elite industry expertise to your biologic program, providing a rock-solid foundation for success. Quality isn’t just a goal — it’s embedded in our culture and drives everything we do. As the only biologics CDMO in Australia approved by the US FDA, BioCina stands apart in capability and compliance. Partner with us and watch your life’s work thrive.
Like Our Own
We Approach Your
Program as a Partner
Our people have walked the full path from research and development through commercial manufacturing. Because we truly understand your journey, we treat your program like it’s our own. Passion, collaboration, and respect define our approach — ensuring every batch receives unmatched care and expertise.
We Deliver
Commitments Kept,
Every Time
Reliable, on-time, in-full delivery is more than a promise — it’s an obsession. Combined with our consistent inspection-ready quality and a client-first partnership mindset, BioCina builds relationships that stand the test of time.
Peerless Value
More Than Just a Proposition
Located strategically in Australia, BioCina offers accelerated timelines to clinical trials and access to attractive tax incentives — giving you faster ROI. Coupled with leading performance in quality, capacity, and capability, we deliver what matters most to our clients: exceptional value and results.
We're Growing for You
At BioCina, growing to ensure we meet the evolving needs of our current and future clients’ isn’t a goal, it’s a given. Our state of the art facilities are manufacturing the medicines of tomorrow and we always stay ahead of emerging technologies and rising market needs.
We are the only US FDA approved biologics CDMO in Australia and we continue to grow our global footprint from that strong foundation.
Our end to end capability, with a rich history of supply of drug product to all major markets, is at your service.